ARGEN X N V has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TRUBION PHARMACEUTICALS, EPIMAB BIOTHERAPEUTICS INC and TRUBION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | China | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Chile | 1 | |
#9 | Colombia | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | New Zealand | 1 | |
#13 | Peru | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Dreier Torsten | 15 |
#2 | De Haard Johannes | 13 |
#3 | Blanchetot Christophe | 13 |
#4 | De Jonge Natalie | 9 |
#5 | De Haard Johannes Joseph Wilhelmus | 8 |
#6 | Ulrichts Peter | 7 |
#7 | Van Der Woning Sebastian Paul | 7 |
#8 | Ongenae Nicolas | 6 |
#9 | Ward Ober E Sally | 5 |
#10 | Ongenae Nicolas G H | 5 |
Publication | Filing date | Title |
---|---|---|
KR20160111937A | Fcrn antagonists and methods of use | |
US2015203840A1 | Method for producing antibody molecules having inter-species, intra-target cross-reactivity |